Paraneoplastic pemphigus associated with Castleman's tumour
S. Caneppele(Hôpital Purpan), J Bazex(Hôpital Purpan), P. Joly(Inserm), N. Picart(Hôpital Purpan), Jochen Paul(Gesundheitsamt), P Bayle-Lebey(Hôpital Purpan), F Oksman(Hôpital Purpan), M. Irsutti(Centre Hospitalier Universitaire de Toulouse)
Cited by 20
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
|Science Translational Medicine|2013|246